Total Valuation
Amgen has a market cap or net worth of $3.55T. The enterprise value is $236.69K.
Market Cap$3.55T
Enterprise Value$236.69K
Share Statistics
Amgen has 539,708,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding539,708,250
Owned by Insiders0.21%
Owned by Institutions1.72%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.89 and return on invested capital (ROIC) is 13.16%.
Return on Equity (ROE)0.89
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)13.16%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee1.17M
Profits Per Employee244.79K
Employee Count31,500
Asset Turnover0.41
Inventory Turnover1.72
Valuation Ratios
The current PE Ratio of Amgen is 26.0. Amgen’s PEG ratio is 0.26.
PE Ratio26.0
PS Ratio4.79
PB Ratio20.34
Price to Fair Value20.34
Price to FCF21.74
Price to Operating Cash Flow18.65
PEG Ratio0.26
Income Statement
In the last 12 months, Amgen had revenue of 36.74B and earned 7.71B in profits. Earnings per share was 14.33.
Revenue36.74B
Gross Profit26.01B
Operating Income10.68B
Pretax Income8.98B
Net Income7.71B
EBITDA16.90B
Earnings Per Share (EPS)14.33
Cash Flow
In the last 12 months, operating cash flow was 10.76B and capital expenditures -2.16B, giving a free cash flow of 8.60B billion.
Operating Cash Flow10.76B
Free Cash Flow8.60B
Free Cash Flow per Share15.93
Dividends & Yields
Amgen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.31
52-Week Price Change17.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)12.00
Important Dates
Amgen upcoming earnings date is Aug 4, 2026, After Close (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateAug 4, 2026
Ex-Dividend Date―
Financial Position
Amgen as a current ratio of 1.14, with Debt / Equity ratio of 623.75%
Current Ratio1.14
Quick Ratio0.90
Debt to Market Cap0.31
Net Debt to EBITDA2.69
Interest Coverage Ratio3.88
Taxes
In the past 12 months, Amgen has paid 1.26B in taxes.
Income Tax1.26B
Effective Tax Rate0.14
Enterprise Valuation
Amgen EV to EBITDA ratio is 13.11, with an EV/FCF ratio of 27.35.
EV to Sales6.03
EV to EBITDA13.11
EV to Free Cash Flow27.35
EV to Operating Cash Flow22.25
Balance Sheet
Amgen has $12.04B in cash and marketable securities with $57.32B in debt, giving a net cash position of -$45.28B billion.
Cash & Marketable Securities$12.04B
Total Debt$57.32B
Net Cash-$45.28B
Net Cash Per Share-$83.91
Tangible Book Value Per Share-$60.03
Margins
Gross margin is 71.46%, with operating margin of 29.06%, and net profit margin of 20.99%.
Gross Margin71.46%
Operating Margin29.06%
Pretax Margin24.43%
Net Profit Margin20.99%
EBITDA Margin45.99%
EBIT Margin31.93%
Analyst Forecast
The average price target for Amgen is $6,267.56, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6,267.56
Price Target Upside― Downside
Analyst ConsensusModerate Buy
Analyst Count24
Revenue Growth Forecast6.14%
EPS Growth Forecast25.83%